Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type

Brooke Sadler, Pamela A Christopherson, Crystal L Perry, Daniel B. Bellissimo, Sandra L Haberichter, Gabe Haller, Lilian Antunes, Veronica H Flood, Jorge Di Paola, Robert R Montgomery, The Zimmerman Program Investigators

Blood (2022) 140 (Supplement 1): 2753–2754.

https://doi.org/10.1182/blood-2022-163383

Published: 2022

Journal Articles

Variability in Bleeding Phenotype in Type 3 VWD Families

Pamela A Christopherson, Veronica H Flood, MD, Sandra L Haberichter, PhD, Joan Cox Gill, MD, Robert R Montgomery, MD, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 2466.

https://doi.org/10.1182/blood-2018-99-112961

Published: 2018

Journal Articles

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Alberto Tosetto, Pamela A Christopherson, Jeroen C.J. Eikenboom, MD, Julie Grabell, CCRP, Paula D. James, MD, Robert R Montgomery, MD, Ian Peake, PhD, Mariana Silva, MD FRCPC, Zimmerman Program Investigators

Blood (2018) 132 (Supplement 1): 1180.

https://doi.org/10.1182/blood-2018-99-115728

Published: 2018

Journal Articles

Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program

Pamela A Christopherson, Crystal L Perry, Daniel B. Bellissimo, PhD, Veronica H Flood, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R. Montgomery, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 19.

https://doi.org/10.1182/blood.V130.Suppl_1.19.19

Published: 2017

Journal Articles

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Jessica Garcia, MD, Pamela A Christopherson, Veronica H Flood, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Paula D. James, MD, Pippa Simpson, PhD, Liyun Zhang, MS, Thomas C. Abshire, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 1075.

https://doi.org/10.1182/blood.V130.Suppl_1.1075.1075

Published: 2017

Journal Articles

Identification of Copy Number Variants in Type 1 and Type 3 VWD by aCGH in the Zimmerman Program

Pamela A Christopherson, Rupa A Udani, PhD, Crystal Perry, BS, Daniel B Bellissimo, PhD, Sandra L Haberichter, PhD, Veronica H Flood, MD, Kenneth D Friedman, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Zimmerman Program Investigators

Blood (2016) 128 (22): 872.

https://doi.org/10.1182/blood.V128.22.872.872

Published: 2016

Journal Articles

Rapid discrimination of the phenotypic variants of von Willebrand disease

Jonathan C. Roberts, Patti A. Morateck, Pamela A. Christopherson, Ke Yan, Raymond G. Hoffmann, Joan Cox Gill, Robert R. Montgomery, the Zimmerman Program Investigators

Blood (2016) 127 (20): 2472–2480.

https://doi.org/10.1182/blood-2015-11-664680

Published: 2016

Includes: Supplemental data

Journal Articles

Crucial role for the VWF A1 domain in binding to type IV collagen

Veronica H. Flood, Abraham C. Schlauderaff, Sandra L. Haberichter, Tricia L. Slobodianuk, Paula M. Jacobi, Daniel B. Bellissimo, Pamela A. Christopherson, Kenneth D. Friedman, Joan Cox Gill, Raymond G. Hoffmann, Robert R. Montgomery, the Zimmerman Program Investigators

Blood (2015) 125 (14): 2297–2304.

https://doi.org/10.1182/blood-2014-11-610824

Published: 2015

Journal Articles

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Pamela A Christopherson, Veronica H Flood, MD, Kenneth D. Friedman, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R Montgomery, MD, Thomas C. Abshire, MD, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1510.

https://doi.org/10.1182/blood.V124.21.1510.1510

Published: 2014

Journal Articles

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

Ashley Cartwright, PhD, Pamela A Christopherson, Crystal L. Perry, Sandra L Haberichter, PhD, Daniel Hampshire, PhD, Ian R. Peake, PhD, Anne Goodeve, PhD, Robert R Montgomery, MD, Daniel B. Bellissimo, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1525.

https://doi.org/10.1182/blood.V124.21.1525.1525

Published: 2014

Journal Articles

A Von Willebrand Factor (VWF) Functional Screening Assay and Its Correlation with Conventional Clinical Assays of VWF Function

Jonathan C Roberts, Pamela A Christopherson, Patti A Morateck, Ke Yan, Raymond G Hoffmann, Joan Cox Gill, MD, Robert R Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 4239.

https://doi.org/10.1182/blood.V124.21.4239.4239

Published: 2014

Journal Articles

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

Joan Cox Gill, MD, Veronica H Flood, MD, Pamela A Christopherson, Daniel B Bellissimo, PhD, Kenneth D Friedman, MD, Sandra L Haberichter, PhD, Rupa A Udani, PhD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 2829.

https://doi.org/10.1182/blood.V124.21.2829.2829

Published: 2014

Journal Articles

Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Daniel B Bellissimo, PhD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Kenneth D Friedman, MD, Rupa A Udani, PhD, Jonathan C Roberts, Robert R Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 472.

https://doi.org/10.1182/blood.V124.21.472.472

Published: 2014

Journal Articles

Regions on Chromosomes 1 and 14 Are Associated with VWF:Ag Levels in African Americans Using Mapping By Admixture Linkage Disequilibrium

Andrew D Paterson, MD, Nicole M Roslin, Pamela A. Christopherson, Daniel B Bellissimo, PhD, Veronica H Flood, MD, Sandra L. Haberichter, PhD, Robert R Montgomery, MD, Zimmerman Program Investigators

Blood (2014) 124 (21): 2840.

https://doi.org/10.1182/blood.V124.21.2840.2840

Published: 2014

Journal Articles

Normal Range Of Bleeding Scores For The ISTH-BAT: Adult and Pediatric Data From The Merging Project

Malak Elbatarny, Shamim Mollah, Julie Grabell, Margaret L. Rand, PhD, Dewi S. Clark, BSc, Andreas Mauer, Pamela A. Christopherson, Robert R. Montgomery, MD, Zimmerman Program Investigators, Barry S. Coller, MD, Paula D. James, MD

Blood (2013) 122 (21): 1107.

https://doi.org/10.1182/blood.V122.21.1107.1107

Published: 2013

Journal Articles

VWF Interaction With Type IV Collagen Is Mediated Through Critical VWF A1 Domain Residues

Veronica H. Flood, MD, Abraham C. Schlauderaff, Paula M. Jacobi, Tricia L. Slobodianuk, Robert R. Montgomery, MD, Sandra L. Haberichter, The Zimmerman Program Investigators

Blood (2013) 122 (21): 29.

https://doi.org/10.1182/blood.V122.21.29.29

Published: 2013

Journal Articles

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

Sandra L. Haberichter, Pamela A. Christopherson, Veronica H. Flood, MD, Joan Cox Gill, MD, Daniel B. Bellissimo, Kenneth D Friedman, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 331.

https://doi.org/10.1182/blood.V122.21.331.331

Published: 2013

Journal Articles

Binding Of VWF To Type IV Collagen: An Additional Collagen Binding Mechanism Beyond Types I, III, and VI Collagen?

Veronica H. Flood, MD, Joan Cox Gill, Sandra L. Haberichter, Daniel B Bellissimo, PhD, Pamela A Christopherson, Kenneth D Friedman, MD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 333.

https://doi.org/10.1182/blood.V122.21.333.333

Published: 2013

Journal Articles

A Novel Rapid Screening Assay for the Diagnosis of the Phenotypic Variants of Von Willebrand Disease (VWD)

Jonathan C Roberts, Patti A Morateck, Pamela A Christopherson, Ke Yan, Raymond G Hoffmann, Joan Cox Gill, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 3567.

https://doi.org/10.1182/blood.V122.21.3567.3567

Published: 2013

Journal Articles

Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD

Robert R. Montgomery, MD, Pamela A. Christopherson, Sandra L Haberichter, PhD, Veronica H Flood, MD, Joan Cox Gill, MD, The Zimmerman Program Investigators

Blood (2011) 118 (21): 381.

https://doi.org/10.1182/blood.V118.21.381.381

Published: 2011

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type

Variability in Bleeding Phenotype in Type 3 VWD Families

Bleeding Patterns in Type I VWD in Effect of VWF Levels: An Individual Participant Data Meta-Analysis of Three Cohorts

Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program

Contribution of Select ISTH-BAT Subscores to the Total Score in Type 1 VWD

Identification of Copy Number Variants in Type 1 and Type 3 VWD by aCGH in the Zimmerman Program

Rapid discrimination of the phenotypic variants of von Willebrand disease

Crucial role for the VWF A1 domain in binding to type IV collagen

Impact of Age and Gender on Bleeding Score in Type 1 VWD Using the ISTH-BAT

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

A Von Willebrand Factor (VWF) Functional Screening Assay and Its Correlation with Conventional Clinical Assays of VWF Function

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program

Regions on Chromosomes 1 and 14 Are Associated with VWF:Ag Levels in African Americans Using Mapping By Admixture Linkage Disequilibrium

Normal Range Of Bleeding Scores For The ISTH-BAT: Adult and Pediatric Data From The Merging Project

VWF Interaction With Type IV Collagen Is Mediated Through Critical VWF A1 Domain Residues

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

Binding Of VWF To Type IV Collagen: An Additional Collagen Binding Mechanism Beyond Types I, III, and VI Collagen?

A Novel Rapid Screening Assay for the Diagnosis of the Phenotypic Variants of Von Willebrand Disease (VWD)

Diagnostic Fidelity of Historically Diagnosed Patients with VWD Enrolled from 27 Centers in the ZPMCB-VWD

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only